A description of the first Candida auris-colonized individuals in New York State, 2016-2017

Am J Infect Control. 2022 Mar;50(3):358-360. doi: 10.1016/j.ajic.2021.10.037. Epub 2021 Nov 15.

Abstract

Candida auris (C. auris) is a globally emerging multidrug-resistant yeast. New York State (NYS) first detected C. auris in July 2016 and is the state most affected. This brief report describes characteristics of the first 114 individuals colonized with C. auris identified through active surveillance/screening by NYS Department of Health. "Colonized/screened" individuals were old (median age, 74 year), had extensive health care exposures and underlying conditions (multiple health care facility admissions in the 90 days prior with more than 80% requiring mechanical ventilation), and had 30- and 90-day mortality rates of 17.5% and 37.7%, respectively (with approximately 60% expired in the 2-year follow-up period). This description is helpful to inform additional prevention measures and add to the collective understanding of C. auris in the United States.

Keywords: Candida auris; colonization; patient and resident characteristics.

Publication types

  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Aged
  • Antifungal Agents / pharmacology
  • Antifungal Agents / therapeutic use
  • Candida auris*
  • Candida*
  • Hospitalization
  • Humans
  • New York / epidemiology
  • United States

Substances

  • Antifungal Agents